Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

New Century Resources, Alcidion Group, Telix Pharmaceutical, Marley Spoon - emerging ASX companies

The Australian stock exchange, which is based in Sydney, has been called the Australian Securities Exchange (ASX) since 2006. Since 1987, the trading place for securities has been located at this central location. Previously, the business with investments in various cities was...
Mario Hose | May 27, 2020 |

This Cannabis Co. Earned a 100% Revenue Increase Over 3 Consecutive Quarters

(Click image to play video) Avicanna Inc. ( TSX: AVCN , OTCQX: AVCNF , Forum ) is a diversified and vertically integrated Canadian biopharmaceutical Company that is focused on the research, development, and commercialization of plant-derived cannabinoid-based products...
Featured Submission | April 20, 2021 |

Stemline Shares Take Off on $677 Million Buyout Offer by Global Pharmaceutical Firm

Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million. Stemline Therapeutics Inc. (STML:NASDAQ) , which is...
Streetwise Reports | May 5, 2020 |

The New Cannabis & CBD Therapy for PTSD

This podcast is part of our StockTalk Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public cannabis marketplace. There are around eight million people in the U...
Stockhouse Media | November 6, 2019 |

Mylan Gets a Shot in the Arm with Pfizer Merger Deal

EpiPen manufacturer Mylan N.V. announced today that the company will merge with Pfizer Inc.'s Upjohn Division, which holds Pfizer's off-patent branded and generic drugs, forming a new company. Mylan Inc. (MYL:NASDAQ) and Pfizer Inc. (PFE:NYSE) today anno...
Streetwise Reports | July 31, 2019 |

West Pharma Services' Shares Rise 10% on Q1 Sales Growth and Raised FY Earnings Guidance

Shares of West Pharmaceutical Services traded higher and established a new 52-week high price after the firm reported Q1/20 earnings that included a 10.8% increase in YoY revenues. Global healthcare packaging components manufacturer company West Pharmaceuti...
Streetwise Reports | April 24, 2020 |

EQS Group, EXMceuticals, Media and Games Invest - Buy recommendations from the experts

Analysts' reports on listed companies serve investors as an external source of information. As a rule, research houses publish their recommendations in connection with financing, the publication of financial statements or in order to increase awareness. The information is usua...
Mario Hose | August 20, 2020 |

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...
Marc Davis | May 10, 2021 |

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis | November 12, 2019 |

Mallinckrodt Shares Up 60% as It Announces Sale of Unit

Shares of Mallinckrodt Plc are trading more than 60% higher today on news that the company is selling its CDMO subsidiary BioVectra Inc. to H.I.G. Capital for $250 million. Global biopharmaceutical company Mallinckrodt Plc (MNK:NYSE) announced today that it has ent...
Streetwise Reports | September 11, 2019 |
1 2 3 4 5 6 7 8 9 10 ...